Medical Robotics Leaders
Tom@terrant
+1.6%
since Sep 19
The idea
I believe surgical and medical robots keep taking procedures from human hands over the next few years, so this leans on the installed leaders already earning money every time their machines get used, with smaller positions in second-wave challengers, hospital automation beyond the operating room, and the parts suppliers who profit no matter which robot wins. Weights stay concentrated in the proven names rather than spread evenly, and about a tenth is held in cash to add on dips. I'd rethink this if hospitals slow adoption or a leader loses its procedure edge.
What it owns
- Companies whose surgical robots are already earning fees per procedure in thousands of hospitals, forming the core of this take. · Intuitive SurgicalIts da Vinci robots are installed in thousands of hospitals and generate recurring revenue from instruments and service each time they operate., StrykerIts Mako robots dominate robotic knee and hip replacements, with each installed system driving years of follow-on implant sales., MedtronicIts Hugo robot pushes into soft-tissue surgery to challenge the established leader, demonstrating the market is expanding rather than just consolidating., Johnson & JohnsonIts Ottava surgical robot builds on the world's largest surgical instruments business, giving it a distribution advantage as it reaches hospitals., Zimmer BiometIts ROSA robots tie hospitals to Zimmer knee and shoulder implants at a lower price point than competitor Mako systems.35%
- Robots and automation beyond the operating room in pharmacies, labs and imaging, riding the same hospital staffing pressures. · Becton DickinsonIt sells automated lab and medication systems into nearly every hospital, capturing the automation trend through steadier revenue streams than operating room equipment., OmnicellIts pharmacy robots automate medication dispensing in hospitals, addressing labor shortages in areas beyond the operating room., GE HealthCareIt makes the imaging systems that surgical robots rely on for navigation, so growth in robotic procedures drives demand for its scanners and guidance tools., DanaherIt owns automated diagnostic and lab equipment that hospitals increasingly use as testing shifts toward machine-run operations.17%
- Smaller challengers pushing robots into spine, urology, cardiology and other procedures the established leaders haven't yet dominated. · Globus MedicalIt leads robotic spine surgery, a procedure category the large soft-tissue robots do not address, proving robots can expand into new surgical areas., Procept BioRoboticsIts Aquablation robot creates its own category in prostate procedures with technology the established players do not match., Smith & NephewIts CORI robot offers a smaller, cheaper option for robotic knee procedures aimed at surgery centers that cannot justify larger systems., StereotaxisIt makes robots that steer catheters through the heart, representing a bet that robotics expands into cardiology procedures.17%
- Suppliers of motion systems, optics and lasers inside medical robots, paid regardless of which robot maker ultimately wins market share. · NovantaIt supplies lasers, precision motion parts and controls inside many medical robots, earning fees regardless of which robot maker succeeds., TeradyneIts Universal Robots arms appear in labs and medical device factories, providing exposure to automation in manufacturing and diagnostics., IPG PhotonicsIt manufactures the fiber lasers used in medical devices and the equipment that produces them, a picks-and-shovels way to gain exposure to robot and device production growth.11%
- Funds holding the wider medical device and robotics sectors, steadying the take if any single company stumbles. · iShares U.S. Medical Devices ETFThis fund holds the entire US medical device sector, providing exposure to the broad trend if individual company selection diverges from expectations., Global X Robotics & AI ETFThis fund owns robotics and automation companies worldwide, providing exposure to the broader automation-adoption theme beyond hospitals alone.10%
- Cash10%